EUVIMEDEUVIMED entdecken
Crossref

Serum YKL-40 as a Predictive Biomarker of Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage Recurrence

Feifan Xu, Jiajie Xu, Qiong Wang, Feng Gao, Jiayu Fu, Tingmeng Yan, Qiang Dong, Ya Su, Xin Cheng

Journal of Alzheimer's Disease · 2024

DOI: 10.3233/jad-231125 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2024. Verfasst von Feifan Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, National Centre for Neurological Disorders, National Clinical Research Centre for Aging and Medicine, Huashan Hospital, Fuda…. Hauptthemen laut MEDLINE: Chitinase-3-Like Protein 1, Cerebral Amyloid Angiopathy, Biomarkers, Cerebral Hemorrhage. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neuroinflammation is a major cause of secondary brain injury in intracerebral hemorrhage (ICH). To date, the prognostic value of YKL-40 (chitinase-3-like-1 protein), a biomarker of neuroinflammation, in cerebral amyloid angiopathy-related intracerebral hemorrhage (CAA-ICH) remains undiscovered.

Objective

To evaluate the relationships between serum YKL-40 and CAA-ICH recurrence.

Methods

Clinical and imaging information of 68 first-onset probable CAA-ICH cases and 95 controls were collected at baseline. Serum YKL-40 was measured by Luminex assay. Cox proportional hazards model was used to analyze the associations between YKL-40 level and CAA-ICH recurrence.

Results

Serum YKL-40 level was significantly higher in CAA-ICH cases than healthy controls (median [interquartile range, IQR], 46.1 [19.8, 93.4] versus 24.4 [13.9, 59.0] ng/mL, p = 0.004). Higher level of YKL-40 predicted increased risk of CAA-ICH recurrence adjusted for age, ICH volume and enlarged perivascular space score (ePVS) (above versus below 115.5 ng/ml, adjusted hazard ratios 4.721, 95% confidence intervals 1.829–12.189, p = 0.001) within a median follow-up period of 2.4 years. Adding YKL-40 to a model of only MRI imaging markers including ICH volume and ePVS score improved the discriminatory power (concordance index from 0.707 to 0.772, p = 0.001) and the reclassification power (net reclassification improvement 28.4%; integrated discrimination index 11.0%).

Conclusions

Serum YKL-40 level might be a candidate prognostic biomarker for CAA-ICH recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chitinase-3-Like Protein 1Cerebral Amyloid AngiopathyBiomarkersCerebral HemorrhageRecurrenceHumansMaleFemaleAgedMiddle AgedAged, 80 and overMagnetic Resonance Imaging

Stichwörter der Autor:innen

Alzheimer’s diseaseYKL-40cerebral amyloid angiopathyintracerebral hemorrhagerecurrence

Substanzen

Chitinase-3-Like Protein 1BiomarkersCHI3L1 protein, human

Autor:innen und Institutionen

  • Department of Neurology, National Centre for Neurological Disorders, National Clinical Research Centre for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Neurology, First Affiliated Hospital of University of Science and Technology of China, Hefei, China.
  • Neurodegenerative Disorder Research Centre and Institute on Aging and Brain Disorders, University of Science and Technology of China, Hefei, China.

Zitieren

APA

Xu, F., Xu, J., Wang, Q., Gao, F., Fu, J., Yan, T., Dong, Q., Su, Y., & Cheng, X. (2024). Serum YKL-40 as a Predictive Biomarker of Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage Recurrence. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-231125

Vancouver

Xu F, Xu J, Wang Q, Gao F, Fu J, Yan T, et al. Serum YKL-40 as a Predictive Biomarker of Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage Recurrence. Journal of Alzheimer's Disease. 2024. doi:10.3233/jad-231125

BibTeX
@article{Xu2024,
  author = {Xu, Feifan and Xu, Jiajie and Wang, Qiong and Gao, Feng and Fu, Jiayu and Yan, Tingmeng and Dong, Qiang and Su, Ya and Cheng, Xin},
  title = {Serum YKL-40 as a Predictive Biomarker of Cerebral Amyloid Angiopathy-Related Intracerebral Hemorrhage Recurrence},
  journal = {Journal of Alzheimer's Disease},
  year = {2024},
  doi = {10.3233/jad-231125}
}
Kostenlos starten →